(Q41965292)

14 October 2017

Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients (English)

1 reference

14 October 2017

1 reference

1 reference

Michiya Kobayashi

1

1 reference

14 October 2017

Junichi Sakamoto

2

1 reference

14 October 2017

Tsutomu Namikawa

3

1 reference

14 October 2017

Ken Okamoto

4

1 reference

14 October 2017

Takehiro Okabayashi

5

1 reference

14 October 2017

Kengo Ichikawa

6

1 reference

14 October 2017

Keijiro Araki

7

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

World Journal of Gastroenterology

14 October 2017

1 reference

14 October 2017

12

1 reference

14 October 2017

9

1 reference

14 October 2017

1412-1415

1 reference

A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

5 June 2018

Intraperitoneal taxol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

Paclitaxel-induced apoptosis in human gastric carcinoma cell lines.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

Taxol stabilizes microtubules in mouse fibroblast cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

Phase I clinical and pharmacokinetic study of taxol.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

Phase I and pharmacodynamic study of taxol in refractory acute leukemias.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

Taxol: a novel investigational antimicrotubule agent

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

Effective weekly paclitaxel administration for gastric cancer with malignant ascites--a case report

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

Phase II trial of outpatient schedule of paclitaxel in patients with previously untreated metastatic, measurable adenocarcinoma of the stomach

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124320

Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study

18 August 2018

1 reference

12 December 2020

Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study

1 reference

12 December 2020

Development of two radioimmunoassays to detect paclitaxel in sera and in cerebrospinal, ascitic, and pleural fluids

1 reference

12 December 2020

Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study

1 reference

12 December 2020

Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma

1 reference

12 December 2020

Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas

1 reference

12 December 2020

Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: a novel, safe, and effective regimen

1 reference

12 December 2020

[A case of metastatic gastric cancer responding to weekly administration of paclitaxel as a second-line therapy]

1 reference

12 December 2020

Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy

1 reference

12 December 2020

Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment

1 reference

12 December 2020

Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V12.I9.1412

1 reference

14 October 2017

1 reference

14 October 2017

PubMed publication ID

16552811

1 reference